Indication
Acute asthma attack
An acute asthma attack, clinically termed an acute asthma exacerbation, is a sudden or progressive worsening of respiratory symptoms and airflow obstruction beyond a patient's baseline. Read more about Acute asthma attack
69 drugs 47 manufacturers
Drugs that treat it
Common Acute asthma attack therapies.
XOPENEX CONCENTRATE (levalbuterol HCl)
PROAIR RESPICLICK (albuterol sulfate)
LEVALBUTEROL TARTRATE HFA (levalbuterol tartrate)
ALBUTEROL SULFATE
LEVALBUTEROL HCL
LEVALBUTEROL HCL
ALBUTEROL SULFATE HFA (albuterol sulfate)
ALBUTEROL SULFATE HFA (albuterol sulfate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn acute asthma attack, clinically termed an acute asthma exacerbation, is a sudden or progressive worsening of respiratory symptoms and airflow obstruction beyond a patient's baseline.
It primarily impacts the lower respiratory tract across pediatric and adult populations with underlying reactive airway disease.
Pathophysiologically, the episode is driven by acute bronchospasm, intense airway mucosal inflammation, and hypersecretion of thick mucus, culminating in significant luminal narrowing and ventilation-perfusion mismatch.
Clinically, it presents with severe dyspnea, wheezing, persistent cough, chest tightness, and marked reductions in objective measures of expiratory airflow, such as peak expiratory flow and forced expiratory volume.
- nih.gov
An acute asthma attack, clinically termed an acute asthma exacerbation, is a sudden or progressive worsening of respiratory symptoms and airflow obstruction beyond a patient's baseline
- nih.gov
An acute asthma attack, clinically termed an acute asthma exacerbation, is a sudden or progressive worsening of respiratory symptoms and airflow obstruction beyond a patient's baseline Clinically, it presents with severe dyspnea, wheezing, persistent cough, chest tightness, and marked reductions in objective measures of expiratory airflow, such as peak expiratory flow and forced expiratory volume
- nih.gov
It primarily impacts the lower respiratory tract across pediatric and adult populations with underlying reactive airway disease
- nih.gov
It primarily impacts the lower respiratory tract across pediatric and adult populations with underlying reactive airway disease
- medlineplus.gov
Pathophysiologically, the episode is driven by acute bronchospasm, intense airway mucosal inflammation, and hypersecretion of thick mucus, culminating in significant luminal narrowing and ventilation-perfusion mismatch
- nih.gov
Clinically, it presents with severe dyspnea, wheezing, persistent cough, chest tightness, and marked reductions in objective measures of expiratory airflow, such as peak expiratory flow and forced expiratory volume
Personalize your experience
Follow Acute asthma attack and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.